Skip to content

Non-invasive neuromodulation for bladder suppression following spinal cord injury

NEUROMOD: Researching the effect of electrical stimulation on bladder overactivity following spinal cord injury in a home pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN17182264
Enrollment
12
Registered
2017-08-21
Start date
2017-08-31
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

UKCRC code/ Disease: Injuries and Accidents/ Injuries to unspecified part of trunk, limb or body region, Renal and Urogenital/ Other disorders of the genitourinary system Urological and Genital Diseases

Interventions

Participants will first record a bladder diary on a provided device for one week. They will then visit the clinic to test the portable stimulation system whilst their bladder's behaviour is measured,

Sponsors

Royal National Orthopaedic Hospital NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Spinal cord injured 2. Aged 18 and over 3. Male or female 4. Injury sustained >6 months ago 5. Urodynamically proven neurogenic detrusor overactivity

Exclusion criteria

Exclusion criteria: 1. Recipient of intra-detrusor botulinum toxin injections within the last 6 months 2. Previous surgical intervention on bladder/sphincters 3. Showing positive leucocytes and nitrites on urinalysis on the day of investigation 4. Pregnancy 5. Cardiac pacemaker 6. Active sepsis 7. History of significant Autonomic Dysreflexia 8. Poorly controlled epilepsy. Acceptable where epilepsy is controlled by drugs or there have been no fits experienced for a reasonable period 9. Patients with a cancerous tumour in the area of the electrical stimulation will be excluded as increased local blood flow may increase tumour growth 10. Patients with exposed orthopaedic metal work in the area of electrical stimulation

Design outcomes

Primary

MeasureTime frame
Bladder overactivity, measured using bladder diary; Timepoint(s): 7 days without intervention, the 7 days with intervention

Secondary

MeasureTime frame
Effect of neuromodulation on bladder overactivity, measured using ambulatory urodynamics conducted at the beginning and at the end of the 7-day period where participants are using the stimulation device

Countries

United Kingdom

Contacts

Public ContactSean Doherty
sean.doherty.15@ucl.ac.uk+44 (0)207 909 5605

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026